Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population

Affiliations

• ¹ Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
• ² Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980 Valencia, Spain.
• ³ Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
• ⁴ Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain.
• ⁵ General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
• ⁶ General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain.
• ⁷ Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain. Electronic address: david.navarro@uv.es.